NCT00692068

Brief Summary

Residual renal function is reported to contribute to the survival and cardiovascular disease of peritoneal dialysis patients. Oxidative and carbonyl stress are increased in peritoneal dialysis patients and are associated with cardiovascular risk. The aim of this study was to determine the relations between residual renal function and oxidative and carbonyl stress in peritoneal dialysis patients.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 6, 2008

Completed
Last Updated

June 6, 2008

Status Verified

June 1, 2008

First QC Date

June 4, 2008

Last Update Submit

June 5, 2008

Conditions

Keywords

residual renal functionoxidative stresscarbonyl stressperitoneal dialysis

Study Arms (2)

A

with residual renal function

B

without residual renal function

Eligibility Criteria

Age10 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

single dialysis center

You may qualify if:

  • chronic renal failure on peritoneal dialysis

You may not qualify if:

  • malignancy, peritonitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Iwata City Hospital

Iwata, Shizuoka, 438-8550, Japan

Location

MeSH Terms

Conditions

Kidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ryuichi Furuya, M.D.

    Iwata City Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 4, 2008

First Posted

June 6, 2008

Last Updated

June 6, 2008

Record last verified: 2008-06

Locations